Verition Fund Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-42,700
Closed -$171K 2679
2025
Q4
$171K Sell
42,700
-647
-1% -$3.6K ﹤0.01% 3220
2025
Q3
$367K Sell
43,347
-110,578
-72% -$1.07M ﹤0.01% 3200
2025
Q2
$1.73M Buy
+153,925
New +$1.41M 0.01% 2057
2025
Q1
Sell
-52,945
Closed -$596K 3431
2024
Q4
$596K Buy
52,945
+6,387
+14% +$112K ﹤0.01% 2371
2024
Q3
$1.32M Buy
46,558
+27,882
+149% +$719K 0.01% 1692
2024
Q2
$357K Sell
18,676
-7,518
-29% -$192K ﹤0.01% 2246
2024
Q1
$859K Buy
26,194
+17,415
+198% +$556K 0.01% 1704
2023
Q4
$290K Buy
8,779
+1,200
+16% +$34K ﹤0.01% 1820
2023
Q3
$206K Sell
7,579
-6,470
-46% -$180K ﹤0.01% 1959
2023
Q2
$426K Buy
14,049
+6,470
+85% +$209K 0.01% 1327
2023
Q1
$246K Sell
7,579
-2,493
-25% -$78.8K ﹤0.01% 1647
2022
Q4
$283K Sell
10,072
-34,005
-77% -$975K ﹤0.01% 1543
2022
Q3
$1.58M Buy
+44,077
New +$1.55M 0.02% 1069
2021
Q2
Sell
-61,892
Closed -$1.25M 1960
2021
Q1
$1.25M Buy
+61,892
New +$1.18M 0.01% 541
2017
Q1
Sell
-19,950
Closed -$295K 1250
2016
Q4
$295K Buy
+19,950
New +$393K 0.03% 835

Other funds holding EVH

Verition Fund Management's EVH Position: Q1 2026 in Review

Verition Fund Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 42,700 shares — an estimated $171K sold.

Verition Fund Management first reported a position in EVH in Q4 2016 and held it in 15 quarters. The position peaked at $1.73M in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Verition Fund Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 42,700 Evolent Health shares in Q1 2026, an estimated $171K.
  • Verition Fund Management first reported a position in Evolent Health in Q4 2016 and held it in 15 quarters.
  • Verition Fund Management's Evolent Health position peaked at $1.73M in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.